Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| MCF 10A | Alvocidib | 0.003162278 | 1.0162 | 0.00317 |
| MCF 10A | Alvocidib | 0.003162278 | 1.0449 | 0.00162 |
| MCF 10A | Alvocidib | 0.01 | 1.0600 | -0.00081 |
| MCF 10A | Alvocidib | 0.01 | 1.0405 | 0.00300 |
| MCF 10A | Alvocidib | 0.01 | 1.0283 | 0.00450 |
| MCF 10A | Alvocidib | 0.031622777 | 1.0374 | -0.00013 |
| MCF 10A | Alvocidib | 0.031622777 | 1.0191 | 0.00628 |
| MCF 10A | Alvocidib | 0.031622777 | 1.0290 | 0.00846 |
| MCF 10A | Alvocidib | 0.1 | 0.8944 | 0.01326 |
| MCF 10A | Alvocidib | 0.1 | 0.8227 | 0.03116 |
| MCF 10A | Alvocidib | 0.1 | 0.7469 | 0.03011 |
| MCF 10A | Alvocidib | 0.316227766 | -0.2554 | 0.29356 |
| MCF 10A | Alvocidib | 0.316227766 | -0.4349 | 0.53574 |
| MCF 10A | Alvocidib | 0.316227766 | -0.3341 | 0.43586 |
| MCF 10A | Alvocidib | 1.0 | -0.5295 | 0.54533 |
| MCF 10A | Alvocidib | 1.0 | -0.7589 | 0.94138 |
| MCF 10A | Alvocidib | 1.0 | 0.99337 | |
| MCF 10A | GSK2334470 | 0.001 | 1.0247 | -0.00204 |
| MCF 10A | GSK2334470 | 0.001 | 1.0051 | 0.00161 |
| MCF 10A | GSK2334470 | 0.001 | 0.9902 | -0.00054 |
| MCF 10A | GSK2334470 | 0.003162278 | 1.0030 | -0.00234 |
| MCF 10A | GSK2334470 | 0.003162278 | 1.0347 | 0.00254 |
| MCF 10A | GSK2334470 | 0.003162278 | 1.0086 | 0.00149 |
| MCF 10A | GSK2334470 | 0.01 | 1.0236 | -0.00383 |
| MCF 10A | GSK2334470 | 0.01 | 1.0378 | 0.00025 |